Insider holders · CIK 0001292519
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Richard John RobertsDirector | 216,887 | — | 216,887 | Apr 20, 2017 · 6:19 pm EDT | Form 4 |
| Mark D PerrinCHIEF EXECUTIVE OFFICER | 58,195 | — | 58,195 | Jan 22, 2016 · 7:36 pm EST | Form 5 |
| Thomas R UlichChief Scientific Officer | 21,693 | — | 21,693 | Jan 22, 2016 · 7:34 pm EST | Form 5 |
| Steven F McAllisterChief Financial Officer | 19,160 | — | 19,160 | Jan 22, 2016 · 7:35 pm EST | Form 5 |
| Tamara L JosephSVP, General Counsel | 17,027 | — | 17,027 | Jan 22, 2016 · 7:35 pm EST | Form 5 |
| Richard M. ToselliSee Remarks | 10,850 | — | 10,850 | Feb 20, 2019 · 4:10 pm EST | Form 4 |
| C Ann MerrifieldDirector | 2,000 | — | 2,000 | Aug 14, 2015 · 4:29 pm EDT | Form 4 |
| Christopher McNultyChief Financial Officer | 922 | — | 922 | Mar 31, 2017 · 3:08 pm EDT | Form 3 |
| Masuoka K. LorianneChief Medical Officer | 265 | — | 265 | Jan 22, 2016 · 7:34 pm EST | Form 5 |
| Pamela J StahlChief Commercial Officer | 0 | — | 0 | Sep 16, 2016 · 4:01 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.